Beyond its role in transcriptional and post-transcriptional regulation, CNOT2 has been implicated in drug resistance, immune evasion, and metabolic reprogramming, underscoring its potential as a key factor in tumor adaptation and therapy resistance. This evidence concerns the gene CNOT2 and neoplasm.